Labeled for this condition
Medicines for atrial fibrillation
17 medicines have an FDA label indicated for atrial fibrillation; 15 are listed from generic labelers and 2 have a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for atrial fibrillation?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Diltiazem | Cardizem, Tiazac, Tiadylt | 50 labelers | $0.144 per capsule 24h ER(cd) 120 mg capsule | No | A presentation being discontinued | 29 |
| Propranolol | Inderal, Innopran, Hemangeol | 42 labelers | $0.0493 per tablet 20 mg tablet | No | In shortage | 4 |
| Warfarin | Jantoven | 19 labelers | $0.093 per tablet 2 mg tablet | Yes | No current entry | 7 |
| Verapamil | none listed | 43 labelers | $0.191 per tablet 180 mg tablet | No | A presentation being discontinued | 7 |
| Heparin | none listed | 18 labelers | $1.18 per mL 5,000 unit/mL vial | No | In shortage | 18 |
| Sotalol | Betapace, Sotylize | 18 labelers | $0.0707 per tablet 80 mg tablet | Yes | No current entry | 1 |
| Digoxin | Lanoxin | 26 labelers | $0.133 per tablet 125 mcg tablet | No | No current entry | 4 |
| Propafenone | none listed | 14 labelers | $0.115 per tablet 150 mg tablet | Yes | No current entry | 5 |
| Dabigatran | Pradaxa | 16 labelers | $0.795 per capsule 150 mg capsule | Yes | No current entry | 9 |
| Rivaroxaban | Xarelto | 20 labelers | $0.650 per tablet 2.5 mg tablet | Yes | A presentation being discontinued | 1 |
| Dofetilide | Tikosyn | 12 labelers | $0.203 per capsule 125 mcg capsule | Yes | No current entry | 6 |
| Esmolol | Brevibloc | 12 labelers | n/a | No | No current entry | 3 |
| Apixaban | Eliquis | 2 labelers | $5.52 per tablet 5 mg tablet | Yes | No current entry | 0 |
| Quinidine | none listed | 4 labelers | $4.92 per tablet 324 mg tablet | Yes | No current entry | 1 |
| Dextrose and heparin | none listed | none listed | n/a | No | No current entry | 3 |
| Edoxaban | Savaysa | none listed | $15.51 per tablet 60 mg tablet | Yes | No current entry | 0 |
| Ibutilide | Corvert | 1 labeler | n/a | Yes | No current entry | 0 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price